Pulse Financial Statements From 2010 to 2026

PLSE Stock  USD 21.42  3.66  14.59%   
Pulse Biosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Pulse Biosciences' valuation are provided below:
Gross Profit
-193 K
Market Capitalization
958.2 M
Enterprise Value Revenue
17.1 K
Revenue
86 K
Earnings Share
(1.14)
There are over one hundred nineteen available trending fundamental ratios for Pulse Biosciences, which can be analyzed over time and compared to other ratios. Investors should ensure to check out all of Pulse Biosciences' recent performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 874.4 M. The current year's Enterprise Value is expected to grow to about 805.3 M

Pulse Biosciences Total Revenue

264,734

Check Pulse Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pulse Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 M, Interest Expense of 1.3 M or Selling General Administrative of 15.8 M, as well as many indicators such as Price To Sales Ratio of 2.5 K, Dividend Yield of 0.0 or PTB Ratio of 12.05. Pulse financial statements analysis is a perfect complement when working with Pulse Biosciences Valuation or Volatility modules.
  
Build AI portfolio with Pulse Stock
Check out the analysis of Pulse Biosciences Correlation against competitors.
For information on how to trade Pulse Stock refer to our How to Trade Pulse Stock guide.

Pulse Biosciences Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets62.4 M94.5 M47.9 M
Slightly volatile
Other Current Liabilities3.1 M3.6 M2.2 M
Slightly volatile
Total Current Liabilities5.4 M7.9 M3.8 M
Slightly volatile
Other Liabilities1.2 M1.1 M1.4 M
Slightly volatile
Net Tangible Assets26.1 M34.1 M21.2 M
Slightly volatile
Property Plant And Equipment Net6.5 M7.1 M4.6 M
Slightly volatile
Current Deferred Revenue22.2 K14.4 K23.2 K
Slightly volatile
Accounts Payable1.6 M2.8 M1.1 M
Slightly volatile
Cash84.8 M80.7 M31.3 M
Slightly volatile
Non Current Assets Total14.5 M11.1 M12.7 M
Slightly volatile
Cash And Short Term Investments46.1 M80.7 M34 M
Slightly volatile
Good Will2.2 M2.5 M2.7 M
Slightly volatile
Common Stock Total Equity17.6 K28.8 K17 K
Slightly volatile
Common Stock Shares Outstanding70.8 M67.4 M24.3 M
Slightly volatile
Liabilities And Stockholders Equity62.4 M94.5 M47.9 M
Slightly volatile
Non Current Liabilities Total11.8 MM8.6 M
Slightly volatile
Other Current Assets1.1 M2.3 M809.8 K
Slightly volatile
Other Stockholder Equity571.1 M543.9 M192.8 M
Slightly volatile
Total Liabilities17.1 M13.9 M12.4 M
Slightly volatile
Property Plant And Equipment Gross7.1 M14.1 M5.5 M
Slightly volatile
Total Current Assets47.9 M83.4 M35.2 M
Slightly volatile
Intangible Assets546.2 K575 K4.9 M
Slightly volatile
Common Stock64.6 K68 K13.3 M
Very volatile
Property Plant Equipment13.6 M12.9 M5.2 M
Slightly volatile
Capital Surpluse115.4 M224.7 M108 M
Slightly volatile
Net Invested Capital138.7 M132.1 M59.9 M
Slightly volatile
Net Working Capital132.1 M125.8 M51.4 M
Slightly volatile
Capital Stock39.9 K75.9 K31.6 K
Slightly volatile
Short and Long Term Debt Total15 M7.5 M12.1 M
Slightly volatile
Capital Lease Obligations10.4 M10.2 M8.1 M
Slightly volatile
Short Term Debt1.4 M1.6 M844.2 K
Slightly volatile
Short and Long Term Debt744.1 K1.1 M575.4 K
Slightly volatile

Pulse Biosciences Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.1 M1.1 M830.6 K
Slightly volatile
Selling General Administrative15.8 M27.5 M11.8 M
Slightly volatile
Other Operating Expenses43.7 M77.3 M30.7 M
Slightly volatile
Research Development47 M44.7 M17 M
Slightly volatile
Total Operating Expenses42.1 M75.7 M29.6 M
Slightly volatile
Interest Income124.5 K131.1 K175.2 K
Pretty Stable
Reconciled Depreciation1.3 M1.4 M1.1 M
Slightly volatile
Selling And Marketing ExpensesM1.1 M5.7 M
Pretty Stable

Pulse Biosciences Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation1.1 M1.1 M830.6 K
Slightly volatile
Capital Expenditures366.9 K315 K363.9 K
Pretty Stable
Total Cash From Financing Activities16.3 M17.2 M30.4 M
Slightly volatile
End Period Cash Flow84.8 M80.7 M32.8 M
Slightly volatile
Change To Liabilities925.5 K1.4 M742.3 K
Slightly volatile
Stock Based Compensation10.8 M21.5 M7.1 M
Slightly volatile
Begin Period Cash Flow123.9 M118 M29.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.5 K2.4 K812
Slightly volatile
Days Sales Outstanding27025792.5205
Slightly volatile
Average Payables118.1 K132.9 K145 K
Slightly volatile
Stock Based Compensation To Revenue57.9355.1821.5706
Slightly volatile
Capex To Depreciation0.510.29410.4438
Very volatile
EV To Sales2.3 K2.2 K757
Slightly volatile
Inventory Turnover11.1910.653.6123
Slightly volatile
Days Of Inventory On Hand33.6835.46772
Slightly volatile
Payables Turnover0.50.521.7908
Slightly volatile
Sales General And Administrative To Revenue13.3517.9414.8532
Slightly volatile
Research And Ddevelopement To Revenue12111544.9081
Slightly volatile
Capex To Revenue0.470.810.4324
Slightly volatile
Cash Per Share1.831.19791.9349
Slightly volatile
Days Payables Outstanding417567385
Slightly volatile
Income Quality0.580.74360.6349
Slightly volatile
Intangibles To Total Assets0.03380.03560.295
Slightly volatile
Current Ratio14.1810.52919.9686
Slightly volatile
Receivables Turnover1.41.4716.8031
Slightly volatile
Capex Per Share0.00440.00470.0266
Slightly volatile
Revenue Per Share0.00570.0060.0383
Slightly volatile
Interest Debt Per Share0.110.11170.4091
Very volatile
Debt To Assets0.07570.07960.2022
Pretty Stable
Operating Cycle346364871
Slightly volatile
Days Of Payables Outstanding417567385
Slightly volatile
Ebt Per Ebit1.160.9461.1953
Slightly volatile
Effective Tax Rate8.0E-49.0E-40.0454
Slightly volatile
Long Term Debt To Capitalization0.07520.07910.8093
Slightly volatile
Total Debt To Capitalization0.08110.08540.2238
Very volatile
Quick Ratio14.1110.511819.9233
Slightly volatile
Net Income Per E B T0.70.90.9265
Very volatile
Cash Ratio10.3810.1917.2832
Slightly volatile
Days Of Inventory Outstanding33.6835.46772
Slightly volatile
Days Of Sales Outstanding27025792.5205
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.181.00581.1643
Slightly volatile
Fixed Asset Turnover0.090.0570.1076
Slightly volatile
Debt Ratio0.07570.07960.2022
Pretty Stable
Price Sales Ratio2.5 K2.4 K812
Slightly volatile
Asset Turnover0.0040.00430.0199
Slightly volatile

Pulse Biosciences Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap874.4 M832.8 M595.2 M
Slightly volatile
Enterprise Value805.3 M766.9 M546.3 M
Slightly volatile

Pulse Fundamental Market Drivers

Pulse Upcoming Events

4th of April 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Pulse Biosciences Financial Statements

Pulse Biosciences stakeholders use historical fundamental indicators, such as Pulse Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Pulse Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pulse Biosciences' assets and liabilities are reflected in the revenues and expenses on Pulse Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pulse Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue14.4 K22.2 K
Total Revenue350 K264.7 K
Cost Of Revenue1.6 MM
Stock Based Compensation To Revenue 55.18  57.93 
Sales General And Administrative To Revenue 17.94  13.35 
Research And Ddevelopement To Revenue 115.00  120.75 
Capex To Revenue 0.81  0.47 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue(252.80)(265.44)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Pulse Biosciences is a strong investment it is important to analyze Pulse Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulse Biosciences' future performance. For an informed investment choice regarding Pulse Stock, refer to the following important reports:
Check out the analysis of Pulse Biosciences Correlation against competitors.
For information on how to trade Pulse Stock refer to our How to Trade Pulse Stock guide.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Will Health Care Equipment & Supplies sector continue expanding? Could Pulse diversify its offerings? Factors like these will boost the valuation of Pulse Biosciences. Anticipated expansion of Pulse directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Pulse Biosciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(1.14)
Revenue Per Share
0.001
Return On Assets
(0.49)
Return On Equity
(0.87)
Investors evaluate Pulse Biosciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Pulse Biosciences' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Pulse Biosciences' market price to deviate significantly from intrinsic value.
It's important to distinguish between Pulse Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pulse Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Pulse Biosciences' market price signifies the transaction level at which participants voluntarily complete trades.